Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

Cited In for PubMed (Select 11828287)

1.

Impact of comorbidity on lung cancer mortality - a report from the Liverpool Lung Project.

Marcus MW, Chen Y, Duffy SW, Field JK.

Oncol Lett. 2015 Apr;9(4):1902-1906. Epub 2015 Jan 28.

2.

Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis.

Kravchenko J, Berry M, Arbeev K, Kim Lyerly H, Yashin A, Akushevich I.

Lung Cancer. 2015 Apr;88(1):85-93. doi: 10.1016/j.lungcan.2015.01.006. Epub 2015 Jan 17.

PMID:
25704956
3.

Impact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitors.

Izquierdo JL, Resano P, El Hachem A, Graziani D, Almonacid C, Sánchez IM.

Int J Chron Obstruct Pulmon Dis. 2014 Sep 30;9:1053-8. doi: 10.2147/COPD.S68766. eCollection 2014.

4.

Comorbidity and survival of Danish lung cancer patients from 2000-2011: a population-based cohort study.

Deleuran T, Thomsen RW, Nørgaard M, Jacobsen JB, Rasmussen TR, Søgaard M.

Clin Epidemiol. 2013 Nov 1;5(Suppl 1):31-8. doi: 10.2147/CLEP.S47473. eCollection 2013.

5.

The impact of comorbidity on cancer survival: a review.

Søgaard M, Thomsen RW, Bossen KS, Sørensen HT, Nørgaard M.

Clin Epidemiol. 2013 Nov 1;5(Suppl 1):3-29. doi: 10.2147/CLEP.S47150. Review.

6.

Surgical treatment of non-small-cell lung cancer in octogenarians.

Guerra M, Neves P, Miranda J.

Interact Cardiovasc Thorac Surg. 2013 May;16(5):673-80. doi: 10.1093/icvts/ivt020. Epub 2013 Feb 8. Review.

7.

Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes.

Shieh SH, Probst JC, Sung FC, Tsai WC, Li YS, Chen CY.

BMC Cancer. 2012 May 11;12:174. doi: 10.1186/1471-2407-12-174.

8.

A comparison of comorbidities obtained from hospital administrative data and medical charts in older patients with pneumonia.

Chong WF, Ding YY, Heng BH.

BMC Health Serv Res. 2011 May 18;11:105. doi: 10.1186/1472-6963-11-105.

9.

Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer.

Cykert S, Dilworth-Anderson P, Monroe MH, Walker P, McGuire FR, Corbie-Smith G, Edwards LJ, Bunton AJ.

JAMA. 2010 Jun 16;303(23):2368-76. doi: 10.1001/jama.2010.793.

10.

Pretreatment predictors of death from other causes in men with prostate cancer.

Simone NL, Singh AK, Cowan JE, Soule BP, Carroll PR, Litwin MS.

J Urol. 2008 Dec;180(6):2447-51; discussion 2451-2. doi: 10.1016/j.juro.2008.08.017. Epub 2008 Oct 19.

11.

Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude.

Strand TE, Rostad H, Damhuis RA, Norstein J.

Thorax. 2007 Nov;62(11):991-7. Epub 2007 Jun 15.

12.

Previous tumour as a prognostic factor in stage I non-small cell lung cancer.

López-Encuentra A, Gómez de la Cámara A, Rami-Porta R, Duque-Medina JL, de Nicolás JL, Sayas J; Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S).

Thorax. 2007 May;62(5):386-90. Epub 2006 Jan 31.

13.

Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer.

Janssen-Heijnen ML, Smulders S, Lemmens VE, Smeenk FW, van Geffen HJ, Coebergh JW.

Thorax. 2004 Jul;59(7):602-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk